Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prospective multicenter safety and efficacy study of initial omidenepag isopropyl therapy in treatment-naive POAG patients (OMDI-Naive-Study)
KCT0010132Phase 4Completed
- Sponsor
- Seoul National University Hospital
- Start
- May 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of omidenepag isopropyl in open-angle glaucoma (OAG), sponsored by Seoul National University Hospital. Started May 2022; status: completed.
02
Drugs
omidenepag isopropyl
03
Conditions
open-angle glaucoma (OAG)
Beyond the preview
Go deeper on KCT0010132.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0010132.